Bernstein Charles N
John Buhler Research Centre, University of Manitoba, 804F-175 McDermot Avenue, Winnipeg, MB, Canada.
J Rheumatol Suppl. 2011 Nov;88:62-5. doi: 10.3899/jrheum.110908.
A series of reports is summarized in which measurement of quality of life (QOL) in various immune-mediated inflammatory diseases (IMID), the parameters that contribute to QOL, and the interrelationship between inflammatory diseases in specific organ systems and psychosocial domains are explored. Current treatment trials in IMID include QOL measures, particularly clinical trials of biologic therapy. There is increasing evidence that several available therapies benefit QOL. Among the factors that contribute to QOL, fatigue, depression, and stress are common and deserve attention from clinicians managing these patients.
一系列报告进行了总结，其中探讨了各种免疫介导的炎症性疾病（IMID）中生活质量（QOL）的测量、影响生活质量的参数，以及特定器官系统中的炎症性疾病与心理社会领域之间的相互关系。目前IMID的治疗试验包括生活质量测量，特别是生物治疗的临床试验。越来越多的证据表明，几种现有疗法对生活质量有益。在影响生活质量的因素中，疲劳、抑郁和压力很常见，值得治疗这些患者的临床医生关注。
